| TRADING CENTER |
| There are no headlines available at this time. |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 56.73 | 0.93 / 1.67% | 10.85 |
| GILD | Gilead Sciences Inc | 43.16 | 0.33 / 0.77% | 16.66 |
| CELG | Celgene Corporation | 56.09 | 0.14 / 0.25% | 67.58 |
| 2008 Revenue: | $9.4 M | Headquarters: Miami, FL |
| Employees: | 61 | CEO: Dr. Phillip Frost, M.D. |
| Net Income: | $-39,834,000.0 | Industry: Biotechnology |
| Market Cap: | $439.0 M | Website: www.opko.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| OPK | 1.74 | +0.01 / +0.58% | 1.73 | 1.75 | 1.68 | Profile Chart News |